Ground Truth Labs

GTL is a digital pathology start-up, which has built a computational platform that uses tissue-based AI to surface diagnostic and prognostic biomarkers that transforms clinical care. The company leverages Oxford’s clinical histopathology excellence and unique datasets with an initial focus on blood cancers.